Patents by Inventor David M. Lough

David M. Lough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090023150
    Abstract: Fast and highly accurate mass spectrometry-based processes for detecting a particular nucleic acid sequence in a biological sample are provided. Depending on the sequence to be detected, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
    Type: Application
    Filed: June 27, 2008
    Publication date: January 22, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Hubert Koster, Daniel P. Little, Andreas Braun, David M. Lough, Guobing Xiang, Dirk van den Boom, Christian Jurinke, Andreas Ruppert
  • Patent number: 6812455
    Abstract: Matrix assisted laser desorption/ionization (MALDI) is performed in a manner that thermalizes large analyte ions in a plume of desorbed material for spectroscopic analysis. The thermalized ions have a low or zero mean velocity and are presented at a well-defined instant in time, reducing artifacts and sharpening the spectral peaks. In one embodiment the light is delivered to a matrix or sample holder having a cover, baffle or compartment. The baffle or compartment impedes or contains a plume of desorbed material and the analyte undergoes collisions to lower its mean velocity and directionality. Thus “thermalized” the analyte ions are passed to a mass analysis instrument.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: November 2, 2004
    Assignee: Sequenom, Inc.
    Inventors: Franz Hillenkamp, David M. Lough, G. Scott Higgins, Dirk Reuter
  • Publication number: 20030129589
    Abstract: Fast and highly accurate mass spectrometry-based processes for detecting a particular nucleic acid sequence in a biological sample are provided. Depending on the sequence to be detected, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
    Type: Application
    Filed: June 28, 1999
    Publication date: July 10, 2003
    Inventors: HUBERT KOSTER, DAVID M. LOUGH, GOUBING XIANG
  • Publication number: 20020109085
    Abstract: Matrix assisted laser desorption/ionization (MALDI) is performed in a manner that thermalizes large analyte ions in a plume of desorbed material for spectroscopic analysis. The thermalized ions have a low or zero mean velocity and are presented at a well-defined instant in time, reducing artifacts and sharpening the spectral peaks. In one embodiment the light is delivered to a matrix or sample holder having a cover, baffle or compartment. The baffle or compartment impedes or contains a plume of desorbed material and the analyte undergoes collisions to lower its mean velocity and directionality. Thus “thermalized” the analyte ions are passed to a mass analysis instrument.
    Type: Application
    Filed: April 3, 2002
    Publication date: August 15, 2002
    Inventors: Franz Hillenkamp, David M. Lough, G. Scott Higgins, Dirk Reuter
  • Patent number: 6423966
    Abstract: Matrix assisted laser desorption/ionization is performed,in a manner to thermalize large analyte ions in a plume of desorbed material for spectroscopic analysis. The thermalized ions have a low or zero mean velocity and are presented at a well-defined instant in time, reducing artifacts and sharpening the spectral peaks. In one embodiment the light is delivered to a matrix or sample holder having a cover, baffle or compartment. The baffle or compartment impedes or contains a plume of desorbed material and the analyte undergoes collisions to lower its mean velocity and directionality. Thus “thermalized” the analyte ions are passed to a mass analysis instrument. In a preferred embodiment an optical fiber butts up against a thin transparent plate on which the specimen resides, with the matrix side in a vacuum acceleration chamber. A mechanical stage moves the specimen in both the x- and y-directions to select a point on the specimen which is to receive the radiation.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: July 23, 2002
    Assignee: Sequenom, Inc.
    Inventors: Franz Hillenkamp, David M. Lough, G. Scott Higgins, Dirk Reuter
  • Publication number: 20020042112
    Abstract: Fast and highly accurate mass spectrometry-based processes for detecting a particular nucleic acid sequence in a biological sample are provided. Depending on the sequence to be detected, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
    Type: Application
    Filed: October 26, 1998
    Publication date: April 11, 2002
    Inventors: HUBERT KOSTER, DANIEL P. LITTLE, ANDREAS BRAUN, DAVID M. LOUGH, GUOBING XIANG, DIRK VAN DEN BOOM, CHRISTIAN JURINKE, ANDREAS RUPPERT
  • Publication number: 20020005478
    Abstract: Matrix assisted laser desorption/ionization is performed in a manner to thermalize large analyte ions in a plume of desorbed material for spectroscopic analysis. The thermalized ions have a low or zero mean velocity and are presented at a well-defined instant in time, reducing artifacts and sharpening the spectral peaks. In one embodiment the light is delivered to a matrix or sample holder having a cover, baffle or compartment. The baffle or compartment impedes or contains a plume of desorbed material and the analyte undergoes collisions to lower its mean velocity and directionality. Thus “thermalized” the analyte ions are passed to a mass analysis instrument. In a preferred embodiment an optical fiber butts up against a thin transparent plate on which the specimen resides, with the matrix side in a vacuum acceleration chamber. A mechanical stage moves the specimen in both the x- and y- directions to select a point on the specimen which is to receive the radiation.
    Type: Application
    Filed: January 14, 2000
    Publication date: January 17, 2002
    Inventors: Franz Hillenkamp, David M. Lough, G. Scott Higgins, Dirk Reuter
  • Patent number: 6268131
    Abstract: A mass spectrometric method for sequencing nucleic acids using RNA polymerases, including DNA-dependent and RNA-dependent RNA polymerases, is provided. The methods use a modified Sanger sequencing strategy in which RNA polymerase is used to generate a set of nested RNA transcripts obtained by base-specific chain termination. These are analyzed by mass spectrometry. A method of identifying transcriptional terminator sequences or attenuator sequences is also provided.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: July 31, 2001
    Assignee: Sequenom, Inc.
    Inventors: Changwon Kang, Young-Soo Kwon, Young Tae Kim, Hubert Köster, Daniel P. Little, Maryanne J. Little, Guobing Xiang, David M. Lough, Charles Cantor
  • Patent number: 6133436
    Abstract: Novel compositions comprised of at least one bead conjugated to a solid support and further conjugated to at least one nucleic acid and preferred methods for making the novel compositions are described. As compared to "flat" surfaces, beads linked to a solid support provide an increased surface area for immobilization of nucleic acids. Furthermore, by selecting a bead with the desired functionality, a practitioner can select a functionalization chemistry for immobilizing nucleic acids, which is different from the chemistry of the solid support.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: October 17, 2000
    Assignee: Sequenom, Inc.
    Inventors: Hubert Koster, David M. Lough
  • Patent number: 5900481
    Abstract: Novel compositions comprised of at least one bead conjugated to a solid support and further conjugated to at least one nucleic acid and preferred methods for making the novel compositions are described. As compared to "flat" surfaces, beads linked to a solid support provide an increased surface area for immobilization of nucleic acids. Furthermore, by selecting a bead with the desired functionality, a practitioner can select a functionalization chemistry for immobilizing nucleic acids, which is different from the chemistry of the solid support.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: May 4, 1999
    Assignee: Sequenom, Inc.
    Inventors: David M. Lough, Hubert Koster
  • Patent number: RE41005
    Abstract: Novel compositions comprised of at least one bead conjugated to a solid support and further conjugated to at least one nucleic acid and preferred methods for making the novel compositions are described. As compared to “flat” surfaces, beads linked to a solid support provide an increased surface area for immobilization of nucleic acids. Furthermore, by selecting a bead with the desired functionality, a practitioner can select a functionalization chemistry for immobilizing nucleic acids, which is different from the chemistry of the solid support.
    Type: Grant
    Filed: October 17, 2002
    Date of Patent: November 24, 2009
    Assignee: Sequenom, Inc.
    Inventors: Hubert Koster, David M. Lough
  • Patent number: RE44693
    Abstract: Novel compositions comprised of at least one bead conjugated to a solid support and further conjugated to at least one nucleic acid and preferred methods for making the novel compositions are described. As compared to “flat” surfaces, beads linked to a solid support provide an increased surface area for immobilization of nucleic acids. Furthermore, by selecting a bead with the desired functionality, a practitioner can select a functionalization chemistry for immobilizing nucleic acids, which is different from the chemistry of the solid support.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: January 7, 2014
    Assignee: Sequenom, Inc.
    Inventors: Hubert Köster, David M. Lough